mounjaro tirzepatide brand name Lilly's Overtakes Merck's 'King Keytruda' as World's Top-Selling Drug Mounjaro is second obesity drug

Exclusion criteria comprised studies lacking relevance to depressive disorders, investigations focused solely on unrelated neurological or systemic conditions, reports involving non-standardized or poorly characterized herbal preparations, and articles without sufficient methodological or outcome detail

Irregular dosing schedules disrupt the steady-state buildup and prolong the adjustment period

The pooled estimated change in HbA 1C from baseline to week 38 was 1.0%-point ( 11.2 mmol/mol)

For general research safety guidance, see our overview of peptide research safety considerations

When estrogen drops, your adrenal glands work harder to compensate, pumping out more cortisol